ViaLase

ViaLase is a clinical-stage medical technology company. ViaLase is committed to breaking the traditional glaucoma treatment paradigm by introducing truly non-invasive image-guided femtosecond laser therapy to enhance care for glaucoma patients. ViaLase's leadership team has extensive experience in developing, designing, manufacturing, and commercializing the first femtosecond laser for ophthalmic surgeries in refractive and cataract patients, and is now bringing this expertise and innovation to glaucoma patients. ViaLase believes in close collaboration with healthcare providers, payers, society, and patients to inform our product development and commercial activities, aiming to deliver this revolutionary treatment method to glaucoma patients worldwide.